These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 10581761)

  • 21. Cholestatic liver disease overlap syndromes.
    Mayo MJ
    Clin Liver Dis; 2013 May; 17(2):243-53. PubMed ID: 23540500
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic and therapeutic questions in overlap syndromes of autoimmune hepatitis.
    Premoli A; Morello E; Bo S; Durazzo M
    Minerva Gastroenterol Dietol; 2007 Mar; 53(1):79-82. PubMed ID: 17415345
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combination therapy of ursodeoxycholic acid and budesonide for PBC-AIH overlap syndrome: a meta-analysis.
    Zhang H; Yang J; Zhu R; Zheng Y; Zhou Y; Dai W; Wang F; Chen K; Li J; Wang C; Li S; Liu T; Abudumijiti H; Zhou Z; Wang J; Lu W; Wang J; Xia Y; Zhou Y; Lu J; Guo C
    Drug Des Devel Ther; 2015; 9():567-74. PubMed ID: 25632224
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autoimmune hepatitis overlap syndromes: an evaluation of treatment response, long-term outcome and survival.
    Al-Chalabi T; Portmann BC; Bernal W; McFarlane IG; Heneghan MA
    Aliment Pharmacol Ther; 2008 Jul; 28(2):209-20. PubMed ID: 18433467
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical management of autoimmune biliary diseases.
    Imam MH; Talwalkar JA; Lindor KD
    J Autoimmun; 2013 Oct; 46():88-96. PubMed ID: 23860242
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Future directions in the medical treatment of primary sclerosing cholangitis: the need for combination drug therapy.
    Fong DG; Lindor KD
    Am J Gastroenterol; 2000 Aug; 95(8):1861-2. PubMed ID: 10950026
    [No Abstract]   [Full Text] [Related]  

  • 27. Primary biliary cirrhosis with additional features of autoimmune hepatitis: response to therapy with ursodeoxycholic acid.
    Joshi S; Cauch-Dudek K; Wanless IR; Lindor KD; Jorgensen R; Batts K; Heathcote EJ
    Hepatology; 2002 Feb; 35(2):409-13. PubMed ID: 11826416
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Medical treatment of chronic cholestasis: ursodeoxycholic acid].
    Linares Rodríguez A
    Gastroenterol Hepatol; 2000 Feb; 23 Suppl 1():24-38. PubMed ID: 11968340
    [No Abstract]   [Full Text] [Related]  

  • 29. Autoimmune hepatitis/primary biliary cirrhosis overlap syndrome developed in a patient with vitiligo and Hashimoto thyroiditis.
    Aksoy EK; Yilmaz B; Köklü S
    Eur J Gastroenterol Hepatol; 2013 Jan; 25(1):121-2. PubMed ID: 23196727
    [No Abstract]   [Full Text] [Related]  

  • 30. Overlap syndrome: autoimmune hepatitis with primary biliary cirrhosis.
    Arulprakash S; Sasi AD; Bala MR; Pugazhendhi T; Kumar SJ
    J Assoc Physicians India; 2010 Jul; 58():455-6. PubMed ID: 21121216
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liver transplantation for primary biliary cirrhosis and primary sclerosing cholangitis: does medical treatment alter timing and selection?
    Hay JE
    Liver Transpl Surg; 1998 Sep; 4(5 Suppl 1):S9-17. PubMed ID: 9742489
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The overlap syndrome of autoimmune hepatitis and primary biliary cirrhosis. Clinical and therapeutic analysis of 5 cases].
    Cheikh I; Said Y; Chaabouni H; Ouerghi H; Ben Ammar A
    Tunis Med; 2003 Jul; 81(7):499-504. PubMed ID: 14534962
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Primary biliary cirrhosis and CREST syndrome: a rare classical combination (literature review and case report)].
    Burnevich EZ; Ignatova TM
    Ter Arkh; 2000; 72(2):66-9. PubMed ID: 10717934
    [No Abstract]   [Full Text] [Related]  

  • 34. Type 2 autoimmune hepatitis overlapping with primary sclerosing cholangitis in a 10-year-old boy.
    Gargouri L; Mnif L; Safi F; Turki F; Majdoub I; Maalej B; Bahri I; Mnif H; Boudawara T; Tahri N; Mahfoudh A
    Arch Pediatr; 2013 Dec; 20(12):1325-8. PubMed ID: 24182664
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medical treatment of primary biliary cirrhosis and primary sclerosing cholangitis.
    Holtmeier J; Leuschner U
    Digestion; 2001; 64(3):137-50. PubMed ID: 11786661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Autoimmune liver disease: diagnosis and therapy].
    Bayer EM; Schramm C; Kanzler S; Lohse AW
    Z Gastroenterol; 2004 Jan; 42(1):19-30. PubMed ID: 14997400
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Immune-mediated liver diseases].
    Pár A
    Orv Hetil; 2007 Apr; 148 Suppl 1():35-8. PubMed ID: 17430792
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Primary biliary cirrhosis].
    Corpechot C
    Gastroenterol Clin Biol; 2003 Mar; 27(3 Pt 1):320-4. PubMed ID: 12700520
    [No Abstract]   [Full Text] [Related]  

  • 39. Ursodeoxycholic acid in the treatment of primary sclerosing cholangitis.
    Stiehl A
    Ital J Gastroenterol; 1996 Apr; 28(3):178-80. PubMed ID: 8789831
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deep cholestatic jaundice as the predominant manifestation in autoimmune hepatitis.
    Wang SB; Wang JH; Zheng RH; Zhong BH; Chen MH
    Hepatogastroenterology; 2010; 57(98):326-9. PubMed ID: 20583436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.